About BIOTECanadaBIOTECanada is the national industry association with nearly 250 members
located nation wide, reflecting the diverse nature of Canada’s health,
industrial and agricultural biotechnology sectors. In addition to
providing significant health benefits for Canadians, the biotechnology
industry has quickly become an essential part of the transformation of
many traditional cornerstones of the Canadian economy including
manufacturing, automotive, energy, aerospace and forestry industries.
Advisory Boards and Committees
Emerging Companies Advisory BoardThis CEO advisory board serves
the needs of small to medium size member companies, most of which do
not yet have major products approved or on the market. It addresses
issues affecting smaller companies and facilitates the development of
BIOTECanada’s programs and policy positions to enhance the development
of these companies.
Health Advisory BoardComprised of representatives from Canada’s
leading-edge developers of biological therapeutics and vaccines, the
board engages leading decision makers on critical issues to ensure
innovative life-saving biotech treatments are developed in Canada and
are available to Canadian citizens. The advisory board acts through a
series of sub-committees to address regulatory, product access,
intellectual property and industrial development issues that affect the
entire biotech health-sector from start-up to multi-national.
Industrial & Agriculture CommitteeThis committee is focused on the development of an strong policy, advocacy, and investment environment in Canada to enable the biotechnology industry to penetrate traditional agricultural and industrial domestic and global markets with bio-derived products and seek solutions to environmental challenges. Specifically, the committee works on issues related to capital formation, regulatory environment, and market awareness and demand. The over 40 committee members are represent leading organizations in industrial and agricultural biotechnology.
Vaccine Industry Committee The VIC is comprised of
Canada’s major vaccine developers and suppliers. Members actively engage
with the federal, provincial and territorial governments to foster full
access and availability of all vaccines including existing, new and
innovative vaccines for all Canadians. The committee also promotes the
high quality nature of Canadian research, development, manufacturing,
and distribution of vaccines, and develops awareness of the value of
vaccines to the Canadian health care system.